Jove
Visualize
Contact Us

Related Concept Videos

Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Curability difference between autochthonous mouse tumors and their transplants in association with immune gene expression.

PloS one·2026
Same author

IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistance.

BJC reports·2026
Same author

ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Cancer research communications·2026
Same author

The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer.

Cancer immunology, immunotherapy : CII·2025
Same author

Peripheral SNCA<sup>+</sup> cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.

Discover oncology·2025
Same author

IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Journal of translational medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 3, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.1K

FSTL1 promotes bone metastasis by causing immune dysfunction.

Chie Kudo-Saito1

  • 1Division of Cellular Signalling; Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo, Japan.

Oncoimmunology
|February 1, 2014
PubMed
Summary

Bone metastasis is poorly understood. Researchers found follistatin-like 1 (FSTL1) protein from cancer cells causes immune dysfunction, promoting bone tumor spread.

Keywords:
ALCAMFSTL1SNAILbone metastasismesenchymal stem cell

More Related Videos

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.4K

Related Experiment Videos

Last Updated: May 3, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.1K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.4K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Metastasis

Background:

  • The link between bone metastasis and antitumor immunity is unclear.
  • Understanding cancer cell dissemination to bone is crucial for effective treatment.

Purpose of the Study:

  • To investigate the role of secreted proteins in bone metastasis.
  • To identify key factors driving immune dysfunction during cancer spread.

Main Methods:

  • Analysis of protein expression in cancer cells.
  • Investigating the effects of identified proteins on the immune system.
  • Studying the impact on bone metastasis in preclinical models.

Main Results:

  • Follistatin-like 1 (FSTL1), secreted by SNAI1-expressing cancer cells, was identified.
  • FSTL1 was found to induce a systemic state of immune dysfunction.
  • This immune dysfunction promotes the development of bone metastasis.

Conclusions:

  • FSTL1 is a critical mediator of bone metastasis.
  • Targeting FSTL1 may offer a novel therapeutic strategy to inhibit cancer spread and restore antitumor immunity.